2,561 reports of this reaction
13.1% of all VIGABATRIN reports
#1 most reported adverse reaction
SEIZURE is the #1 most commonly reported adverse reaction for VIGABATRIN, manufactured by Lundbeck Pharmaceuticals LLC. There are 2,561 FDA adverse event reports linking VIGABATRIN to SEIZURE. This represents approximately 13.1% of all 19,478 adverse event reports for this drug.
Patients taking VIGABATRIN who experience seizure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SEIZURE is a frequently reported adverse event for VIGABATRIN, accounting for a significant proportion of all reports.
In addition to seizure, the following adverse reactions have been reported for VIGABATRIN:
The following drugs have also been linked to seizure in FDA adverse event reports:
SEIZURE has been reported as an adverse event in 2,561 FDA reports for VIGABATRIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
SEIZURE accounts for approximately 13.1% of all adverse event reports for VIGABATRIN, making it one of the most commonly reported side effect.
If you experience seizure while taking VIGABATRIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.